Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up.

Gutkin PM, Hiniker SM, Swetter SM, Reddy SA, Knox SJ.

Cureus. 2018 Dec 12;10(12):e3723. doi: 10.7759/cureus.3723.

2.

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.

Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM, Reddy SA, Boulmay BC, Riker AI, Burgess MA, Hanks BA, Olencki T, Margolin K, Lundgren LM, Soni A, Ramchurren N, Church C, Park SY, Shinohara MM, Salim B, Taube JM, Bird SR, Ibrahim N, Fling SP, Homet Moreno B, Sharon E, Cheever MA, Topalian SL.

J Clin Oncol. 2019 Mar 20;37(9):693-702. doi: 10.1200/JCO.18.01896. Epub 2019 Feb 6.

PMID:
30726175
3.

Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CT.

Nobashi T, Baratto L, Reddy SA, Srinivas S, Toriihara A, Hatami N, Yohannan TK, Mittra E.

Clin Nucl Med. 2019 Apr;44(4):e272-e279. doi: 10.1097/RLU.0000000000002453.

PMID:
30688730
4.

Patterns of Recurrence, Long-term Survival and Toxicity Analysis of Endometrial Adenocarcinoma Patients Reclassified Under the Recent ESMO-ESGO-ESTRO Stratification: Seven-Year Results From a Single Institution.

Kumar UP, Yathiraj PH, Sharan KT, Kamath A, Singh A, Reddy SA, Alurkar P, Fernandes DJ, Mamidipudi VS.

Int J Gynecol Cancer. 2018 Jun;28(5):854-860. doi: 10.1097/IGC.0000000000001252.

PMID:
29683879
5.

Authors' Response.

Mohan A, Reddy SA, Sachan A, Sarma KVS, Kumar DP, Panchagnula MV, Rao PVLNS, Kumar BS, Krishnaprasanthi P.

Indian J Med Res. 2017 Apr;145(4):573-574. doi: 10.4103/0971-5916.213767. No abstract available.

6.

Phase I Trial: SABR and Ipilimumab-Letter.

Hiniker SM, Reddy SA, Swetter SM, Knox SJ.

Clin Cancer Res. 2017 Jan 1;23(1):320. doi: 10.1158/1078-0432.CCR-16-2495. No abstract available.

7.

Derivation & validation of glycosylated haemoglobin (HbA 1c ) cut-off value as a diagnostic test for type 2 diabetes in south Indian population.

Mohan A, Reddy SA, Sachan A, Sarma K, Kumar DP, Panchagnula MV, Rao PS, Kumar BS, Krishnaprasanthi P.

Indian J Med Res. 2016 Aug;144(2):220-228. doi: 10.4103/0971-5916.195035.

8.

A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma.

Hiniker SM, Reddy SA, Maecker HT, Subrahmanyam PB, Rosenberg-Hasson Y, Swetter SM, Saha S, Shura L, Knox SJ.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):578-88. doi: 10.1016/j.ijrobp.2016.07.005. Epub 2016 Jul 15.

9.

Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome): Use in a community setting.

Reddy SA.

Crit Rev Oncol Hematol. 2016 Oct;106:99-107. doi: 10.1016/j.critrevonc.2016.07.001. Epub 2016 Jul 5. Review.

10.

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, Berry S, Chartash EK, Daud A, Fling SP, Friedlander PA, Kluger HM, Kohrt HE, Lundgren L, Margolin K, Mitchell A, Olencki T, Pardoll DM, Reddy SA, Shantha EM, Sharfman WH, Sharon E, Shemanski LR, Shinohara MM, Sunshine JC, Taube JM, Thompson JA, Townson SM, Yearley JH, Topalian SL, Cheever MA.

N Engl J Med. 2016 Jun 30;374(26):2542-52. doi: 10.1056/NEJMoa1603702. Epub 2016 Apr 19.

11.

Design, Synthesis, and Evaluation of Novel 1,2,3-Triazole-Tethered Glycolipids as Vaccine Adjuvants.

Bhunia D, Pallavi PM, Bonam SR, Reddy SA, Verma Y, Halmuthur MS.

Arch Pharm (Weinheim). 2015 Oct;348(10):689-703. doi: 10.1002/ardp.201500143. Epub 2015 Sep 2.

PMID:
26332372
12.

Thioredoxin-dependent regulation of AIF-mediated DNA damage.

Shelar SB, Kaminska KK, Reddy SA, Kumar D, Tan CT, Yu VC, Lu J, Holmgren A, Hagen T, Chew EH.

Free Radic Biol Med. 2015 Oct;87:125-36. doi: 10.1016/j.freeradbiomed.2015.06.029. Epub 2015 Jun 25.

PMID:
26119781
13.

Sulforaphane and its methylcarbonyl analogs inhibit the LPS-stimulated inflammatory response in human monocytes through modulating cytokine production, suppressing chemotactic migration and phagocytosis in a NF-κB- and MAPK-dependent manner.

Reddy SA, Shelar SB, Dang TM, Lee BN, Yang H, Ong SM, Ng HL, Chui WK, Wong SC, Chew EH.

Int Immunopharmacol. 2015 Feb;24(2):440-450. doi: 10.1016/j.intimp.2014.12.037. Epub 2015 Jan 10.

PMID:
25585231
14.

Novel 2,5-disubstituted-1,3,4-oxadiazoles as anti-inflammatory drugs.

Durgashivaprasad E, Mathew G, Sebastian S, Reddy SA, Mudgal J, Nampurath GK.

Indian J Pharmacol. 2014 Sep-Oct;46(5):521-6. doi: 10.4103/0253-7613.140584.

15.

Atenolol and amlodipine combination overdose managed with continuous venovenous hemodiafiltration: A case report.

Sandeep P, Ram R, Sowgandhi N, Reddy SA, Katyarmal DT, Kumar BS, Kumar VS.

Indian J Nephrol. 2014 Sep;24(5):327-9. doi: 10.4103/0971-4065.133033.

16.

Chilaiditi's syndrome.

Rajender M, Kumar VA, Rao R, Raghukanth A, Reddy SA.

Indian J Chest Dis Allied Sci. 2014 Apr-Jun;56(2):117-9.

PMID:
25230554
17.

3-(2-oxoethylidene)indolin-2-one derivatives activate Nrf2 and inhibit NF-κB: potential candidates for chemoprevention.

Nagle AA, Reddy SA, Bertrand H, Tajima H, Dang TM, Wong SC, Hayes JD, Wells G, Chew EH.

ChemMedChem. 2014 Aug;9(8):1763-74. doi: 10.1002/cmdc.201402038. Epub 2014 May 12.

PMID:
24819554
18.

Primary percutaneous coronary intervention in a patient with haemophilia a.

Reddy SA, Hoole SP, Besser MW.

Case Rep Med. 2013;2013:189796. doi: 10.1155/2013/189796. Epub 2013 Dec 19.

19.

Development of a genotyping microarray for studying the role of gene-environment interactions in risk for lung cancer.

Baldwin DA, Sarnowski CP, Reddy SA, Blair IA, Clapper M, Lazarus P, Li M, Muscat JE, Penning TM, Vachani A, Whitehead AS.

J Biomol Tech. 2013 Dec;24(4):198-217. doi: 10.7171/jbt.13-2404-004.

20.

A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways.

Gan FF, Ling H, Ang X, Reddy SA, Lee SS, Yang H, Tan SH, Hayes JD, Chui WK, Chew EH.

Toxicol Appl Pharmacol. 2013 Nov 1;272(3):852-62. doi: 10.1016/j.taap.2013.07.011. Epub 2013 Jul 27.

PMID:
23899529
21.

Facile formation of stable tris(imido)phosphate trianions as their tri- and hexanuclear Pd(II) complexes in protic solvents.

Gupta AK, Reddy SA, Boomishankar R.

Inorg Chem. 2013 Jul 1;52(13):7608-14. doi: 10.1021/ic400686e. Epub 2013 Jun 10.

PMID:
23750700
22.

BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiation.

Yao Y, Suraokar M, Darnay BG, Hollier BG, Shaiken TE, Asano T, Chen CH, Chang BH, Lu Y, Mills GB, Sarbassov D, Mani SA, Abbruzzese JL, Reddy SA.

Sci Signal. 2013 Jan 8;6(257):ra2. doi: 10.1126/scisignal.2003295.

23.

Binary function of mRNA.

Kloc M, Foreman V, Reddy SA.

Biochimie. 2011 Nov;93(11):1955-61. doi: 10.1016/j.biochi.2011.07.008. Epub 2011 Jul 28. Review.

PMID:
21784124
24.

Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.

Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, Campbell S, Reddy SA, Krishnan K.

Free Radic Biol Med. 2011 Sep 15;51(6):1164-74. doi: 10.1016/j.freeradbiomed.2011.06.008. Epub 2011 Jun 21.

PMID:
21723941
25.

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.

Javle MM, Shroff RT, Xiong H, Varadhachary GA, Fogelman D, Reddy SA, Davis D, Zhang Y, Wolff RA, Abbruzzese JL.

BMC Cancer. 2010 Jul 14;10:368. doi: 10.1186/1471-2407-10-368.

26.

A phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders.

Duvic M, Reddy SA, Pinter-Brown L, Korman NJ, Zic J, Kennedy DA, Lorenz J, Sievers EL, Kim YH.

Clin Cancer Res. 2009 Oct 1;15(19):6217-24. doi: 10.1158/1078-0432.CCR-09-0162. Epub 2009 Sep 29.

27.

Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism.

Shin S, Asano T, Yao Y, Zhang R, Claret FX, Korc M, Sabapathy K, Menter DG, Abbruzzese JL, Reddy SAG.

Mol Cancer Res. 2009 May;7(5):745-754. doi: 10.1158/1541-7786.MCR-08-0462. Epub 2009 May 12.

28.

Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells.

Sui X, Shin S, Zhang R, Firozi PF, Yang L, Abbruzzese JL, Reddy SA.

Oncogene. 2009 Feb 5;28(5):709-20. doi: 10.1038/onc.2008.423. Epub 2008 Nov 24.

PMID:
19029954
29.

Constitutive activation of AKT pathway inhibits TNF-induced apoptosis in mitochondrial DNA-deficient human myelogenous leukemia ML-1a.

Suzuki S, Naito A, Asano T, Evans TT, Reddy SA, Higuchi M.

Cancer Lett. 2008 Sep 8;268(1):31-7. doi: 10.1016/j.canlet.2008.03.020. Epub 2008 May 12.

30.

Extractive spectrophotometric determination of trace amounts of cadmium(II) in medicinal leaves and environmental samples using benzildithiosemicarbazone (BDTSC).

Reddy SA, Reddy KJ, Lakshminaraya S, Priya DL, Rao YS, Reddy AV.

J Hazard Mater. 2008 Apr 15;152(3):903-9. Epub 2007 Jul 27.

PMID:
17825486
31.

Diagnosis of transmesocolic internal hernia as a complication of retrocolic gastric bypass: CT imaging criteria.

Reddy SA, Yang C, McGinnis LA, Seggerman RE, Garza E, Ford KL 3rd.

AJR Am J Roentgenol. 2007 Jul;189(1):52-5.

PMID:
17579151
32.

Establishment of three-dimensional cultures of human pancreatic duct epithelial cells.

Gutierrez-Barrera AM, Menter DG, Abbruzzese JL, Reddy SA.

Biochem Biophys Res Commun. 2007 Jul 6;358(3):698-703. Epub 2007 May 4.

33.
34.

PTEN down regulates AP-1 and targets c-fos in human glioma cells via PI3-kinase/Akt pathway.

Koul D, Shen R, Shishodia S, Takada Y, Bhat KP, Reddy SA, Aggarwal BB, Yung WK.

Mol Cell Biochem. 2007 Jun;300(1-2):77-87. Epub 2007 Jan 18.

PMID:
17235455
35.

Hypothesis generation in signaling networks.

Ruths DA, Nakhleh L, Iyengar MS, Reddy SA, Ram PT.

J Comput Biol. 2006 Nov;13(9):1546-57.

PMID:
17147477
36.

c-Jun promotes cellular survival by suppression of PTEN.

Hettinger K, Vikhanskaya F, Poh MK, Lee MK, de Belle I, Zhang JT, Reddy SA, Sabapathy K.

Cell Death Differ. 2007 Feb;14(2):218-29. Epub 2006 May 5.

37.

Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells.

Asano T, Yao Y, Shin S, McCubrey J, Abbruzzese JL, Reddy SA.

Cancer Res. 2005 Oct 15;65(20):9164-8.

38.

Altered mental status in a 66-year-old woman during the late summer months.

Reddy SA, Schucany WG, Opatowsky MJ.

Proc (Bayl Univ Med Cent). 2004 Jul;17(3):353-6. No abstract available.

39.

The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation.

Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA.

Biochem Biophys Res Commun. 2005 May 27;331(1):295-302.

PMID:
15845392
40.

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.

Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA.

Oncogene. 2004 Nov 11;23(53):8571-80. Erratum in: Oncogene. 2005 Jun 16;24(26)4320.

PMID:
15467756
41.

The IL-1 receptor accessory protein is essential for PI 3-kinase recruitment and activation.

Reddy SA, Lin YF, Huang HJ, Samanta AK, Liao WS.

Biochem Biophys Res Commun. 2004 Apr 16;316(4):1022-8.

PMID:
15044087
42.

Molecular rescue of tumour-specific T cell receptor idiotype from T cell lymphomas.

Reddy SA, Levy R.

Br J Haematol. 2004 Mar;124(5):626-8.

PMID:
14871249
43.

Non-invasive hemostatic closure devices: "patches and pads".

Hirsch JA, Reddy SA, Capasso WE, Linfante I.

Tech Vasc Interv Radiol. 2003 Jun;6(2):92-5.

PMID:
12903003
44.

Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.

Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM, Menter DG.

J Biol Chem. 2003 Oct 17;278(42):41338-46. Epub 2003 Aug 4.

46.

T cell antigen receptor vaccines for active therapy of T cell malignancies.

Reddy SA, Okada C, Wong C, Bahler D, Levy R.

Ann N Y Acad Sci. 2001 Sep;941:97-105.

47.

Signaling pathways in pancreatic cancer.

Reddy SA.

Cancer J. 2001 Jul-Aug;7(4):274-86. Review.

PMID:
11561604
48.

Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway.

Koul D, Yao Y, Abbruzzese JL, Yung WK, Reddy SA.

J Biol Chem. 2001 Apr 6;276(14):11402-8. Epub 2001 Jan 12.

49.

Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.

Stockerl-Goldstein KE, Reddy SA, Horning SF, Blume KG, Chao NF, Hu WW, Johnston LF, Long GD, Strober S, Wong RM, Feiner RH, Kobler S, Negrin RS.

Biol Blood Marrow Transplant. 2000;6(5):506-12.

Supplemental Content

Loading ...
Support Center